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Supporting Information Synthesis of brightly PEGylated luminescent magnetic upconversion nanophosphors for deep tissue and dual MRI imaging
Ethanol (anhydrous, denatured) was obtained from BDH Chemicals Ltd (Poole, Dorset, UK).
Deionized (DI) water and hexanes (HPLC grade) was purchased from EMD Chemicals Inc.
(Gibbstown, NJ). Polyvinylpyrrolidone (PVP K-30, MW 40,000) and oleic acid (95%) were purchased from Spectrum Chemicals (Gardena, CA). Agarose (low melting point) was purchased from USB Corporation (Cleveland, OH). All chemicals were used as received without further purification. were added in 350 ml distilled water with 1.8 g PVP. After the solution was heated to 80 °C, 3.5 g urea was added to the solution. The solution was aged at 80 °C for 50 min, cooled to room temperature in ice water. The resulting precipitate was centrifuged and washed three times with DI water before the polyelectrolytes coating. The washed precursor was resuspended in 8 ml distilled water with 4 ml aqueous solution of sodium alginate (2 mg/mL) containing 0.25 M NaCl. The solution was sonicated for 10 min, washed with DI water for three times to remove excess sodium alginate. The obtained particles were re-dispersed in 10 ml DI water. The PEI coating was performed by adding 2 ml of PEI solution (5 mg/mL, NaCl 0.5 M) to the particle solution and the solution was sonicated for 10 min. After 100 mg NH 4 F was added to the particle solution followed by stirring for 10 min, 60 ml glycerol was added to the solution and this mixture was maintained at 80 ˚C for 3 h. The particles was then collected by centrifugation and washed with DI water three times. The NaGdF 4 :Yb/Er or NaGdF 4 :Yb/Tm nanoparticles was obtained by incubating these particles in 15 ml NaF (5 mg/ml) and PEI (5 mg/ml) mixed 
Synthesis of PEGylated upconversion nanophosphors
Synthesis of oleic acid capped Fe 3 O 4 nanoparticles and its surface modification
Monodispersed oleic acid capped Fe 3 O 4 nanoparticles were prepared according to the method described by Park and coworkers.
[38] Precursor of iron-oleate complex was first synthesized. 10 mmol of iron (III) chloride and 30 mmol of sodium oleate were dissolved in a mixture solvent composed of 20 ml ethanol, 15 ml DI water and 35 ml hexane. The resulting solution was heated to 60 °C and kept at that temperature for 4 hours. When the reaction was completed, the upper organic layer containing the iron-oleate complex was washed three times with 30 ml DI water in a separatory funnel. The upper organic layer was collected for further use. 10 mmol of the ironoleate complex synthesized as described above and 10 mmol of oleic acid were dissolved in 75 g of 1-octadecene at room temperature. The reaction mixture was heated to 110 °C with a constant heating rate of 5 °C min -1 and then kept at that temperature for 30 min with nitrogen bubbling.
Then the solution was further heated to 320 °C with the same heating rate, and kept at that temperature for one hour. The resulting solution containing the nanoparticles was cooled to room temperature afterwards, and was precipitated by adding 500 ml acetone and centrifuged at 10000 rpm for 15 min. Then the Fe 3 O 4 particles were redispersed in hexane. The whole purification process was repeated two more times.
To obtain momodisperse hydrophoilic Fe 3 O 4 nanoparticles, NaIO 4 was used to oxidize the ligands of oleic acid. 30 ml hexane solution of oleic acid capped Fe 3 O 4 nanoparticle was added to 30 ml mixture of ethyl acetate (15 ml) and acetonitrile (15 ml). The solution was sonicated in ice water for two hours after mixed with 30 ml of sodium periodate aqueous solution (0.28 M).
The bottom aqueous layer was collected and the Fe 3 O 4 nanoparticles were magnetically separated and washed with ethanol and distilled water for three times, separately. The hydrophilic Fe 3 O 4 nanoparticles were re-suspended in distilled water prior to use.
Synthesis of PEGylated magnetic upconversion nanophosphors
To obtain monodispersed magnetic upconversion phosphors, the monodispersed washed precursor was re-suspended in 8 ml DI water with 4 ml aqueous solution of sodium alginate (2 mg/ml) containing 0.25 M NaCl. The solution was sonicated for 10 min, washed with DI water for three times and re-dispersed in 10 ml DI water. The second layer of polyelectrolyte coating was performed by adding 2 ml of PEI solution (5 mg/ml, NaCl 0.5M) to particle solution and the solution was sonicated for 10 min. After 100 mg NH 4 F was added to the solution and stirred for 10 min, 60 ml glycerol was added to the solution and this mixture was maintained at 80 ˚C for 3 h. The particles was then collected by centrifugation and washed with DI water three times. The NaGdF 4 :Yb/Er or NaGdF 4 :Yb/Tm was obtain by incubating these particles in 15 ml NaF (5 mg/ml) and PEI (5 mg/ml) mixed solution at 200 ˚C for 8 h. The upconversion phosphors were finally collected and rinsed three times with DI water. The DCC/NHS involved conjugation method was employed to functionalize the upconversion nanophosphors with PEG. 
Sample preparation for magnetic resonance imaging (MRI)
T 1 and T 2 MR measurements were acquired for upconversion phosphor and magnetic upconversion phosphors particles at a series of concentrations. The particles were dispersed in 1 % agarose gel at 80 °C and cooled to room temperature in NMR tubes to set the gel. The gel prevented settling and aggregation allowing MRI imaging several days after preparation.
Cell viability test
MCF-7 breast cancer cells were seeded at a density of 10,000 cells/well in a 96-well plate.
Cells were stored at 37 °C at 5% CO 2 and attached to the plate overnight. Nanoparticles were suspended in media, sonicated for 10 minutes to disperse, and diluted to 1000, 500, 250, 100, and 50 µg/ml. Media was removed from wells and fresh media or nanoparticle in media was added to each well. Five repeats were done for each concentration. Nanoparticles were incubated with cells overnight and the next day a Presto Blue assay (Life Technologies) was performed. Media was removed and 100 µl of a 1:9 ratio Presto Blue in culture media was added to each well.
Cells were incubated at 37 °C and 5% CO 2 for 45 minutes. Fluorescent intensity was taken with a plate reader with an excitation wavelength of 560 nm and an emission wavelength of 590 nm.
Fluorescent intensity for each concentration of nanoparticle was normalized as a percentage of the fluorescent intensity of the control cells. Percent viability averages were plotted with error bars of one standard deviation.
Characterization methods
Transmission and scanning electron microscopy (TEM) were performed on a H9500 operated at 300 kV and HD2000 microscope operated at 100 kV, respectively. An X-ray diffractometer (Rigaku; MiniFlex, Cu Kα) was used to characterize the XRD pattern of the prepared nanoparticles. Upconversion luminescence images were captured in an IVIS Lumina-XR Imaging System (Caliper Life Sciences, Hopkinton, MA, US) with 1 s exposure time, in "bioluminescence mode," during irradiation with a 980 nm fiber coupled diode laser. The Zetapotential of nanoparticles was measured with a Zetasizer Nano ZS (equipped with a 633 nm HeNe laser) from Malvern Instruments. Prior to the experiment, the particles were diluted in distilled water (0.1 mg/ml). Magnetization measurements were performed at 300 K using vibrating sample magnetometer (VSM) option of physical property measurement system (PPMS, Quantum Design, USA), with the applied magnetic field sweeping between +/-3.0 Tesla at a rate of 50 Oe/sec. The switching motion of the magnet at 90º to control the orientation of magnetic particles was programmed with motion control software (Si Programmer; Applied Motion Products, Watsonville, CA) at 3 s interval. Determination of the gadolinium and iron content in a sample was performed by inductively coupled plasma (ICP) (Optima 3100 RL, Perkin-Elmer).
Thermal gravimetric analysis (TGA) was carried by Hi-Res TGA 2950 thermogravimetric analyzer and Fourier transform infrared spectra (FTIR) was taken by Thermo-Nicolet Magna 550
FTIR.
All MRI experiments were performed on a Varian 4.7 T horizontal bore imaging system (Agilent Inc, Santa Clara, CA). Samples, contained in 5 mm NMR tubes, were placed in a 63 mm inner diameter quadrature RF coil for imaging. MRI gradient echo scout images were collected in all three imaging planes (axial, coronal, and sagittal) for subsequent image planning, with repetition time (TR) = 100 ms, echo time (TE) = 4 ms, number of slices =20, slice thickness =2, matrix size 128×128, field of view (FOV) = 40 mm×40 mm, number of acquisitions (NEX) =2. Relaxivity measurements were then collected on a single 2 mm thick imaging slice, approximately perpendicular to the long axis of the NMR tubes. T 2 relaxivity measurements were acquired with FOV = 36 mm×36 mm, using a multi-spin echo imaging sequence with TR = 3000, NEX = 10, echo spacing = 4ms, number of echoes = 10, and 128 x 128 matrix. T 1 relaxivity measurements were acquired using the same slice geometry and imaging matrix with a segmented fast low angle shot (FLASH) sequence with inversion recovery with inversion times of 50, 97, 186, 360, 695, 1341, 2590 , and 5000ms, with TR = 6000 ms, TE = 2.1ms, and NEX =8. 
